These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14850834)

  • 21. [Research on blood coagulation in roentgenotherapy of leukemia. III. Action of irradiated leukemic plasma on plasma coagulation in normal and hemophilic subjects].
    TROPEANO L; DI GUGLIELMO L
    Boll Soc Ital Biol Sper; 1950; 26(11-12):1550-1. PubMed ID: 14839100
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O; Valentin S; Beck TC; Hedner U
    Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemophilia and blood coagulation].
    VAN CREVELD S
    Ned Tijdschr Geneeskd; 1956 May; 100(21):1523-38; discussion, 1539. PubMed ID: 13348719
    [No Abstract]   [Full Text] [Related]  

  • 24. [CLINICAL ASPECTS AND TREATMENT OF HEMOPHILIA IN CHILDREN].
    STEPANOVA MN; DUBROV EIa
    Sov Med; 1964 Mar; 27():104-9. PubMed ID: 14177334
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple congenital coagulation deficiencies.
    BONNIN JA; HICKS ND; INNIS MD; SIMPSON DA
    J Clin Pathol; 1960 Jul; 13(4):311-4. PubMed ID: 13802579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research on the antithromboplastin factors in hemophilia. 1. The plasma antithromboplastin of Tocantins].
    CHEVALLIER P; FIEHRER A; BILSKI-PASQUIER G; SAMAMA M
    Sang; 1955; 26(4):362-76. PubMed ID: 13246570
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet coagulant activities: evidence for multiple different functions of platelets in intrinsic coagulation.
    Walsh PN
    Ser Haematol; 1973; 6(4):579-92. PubMed ID: 4795011
    [No Abstract]   [Full Text] [Related]  

  • 28. [Application of the plasma-agarose gel diffusion method to the detection and measurement of anti-Factor-VIII:C and other inhibitors of coagulation].
    Jorquera JI; Carmona E; Aznar JA; Cañada M; Peiró A; Sánchez-Cuenca JM
    Sangre (Barc); 1985; 30(4-A):411-6. PubMed ID: 2416066
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of hydergin on blood coagulation time in 3 cases of hemophilia].
    JELAVIC N; VODOPIVEC M
    Lijec Vjesn; 1951; 73(2-3):37-9. PubMed ID: 14833059
    [No Abstract]   [Full Text] [Related]  

  • 30. [ON THE ORIGIN OF THE ERYTHROCYTIC THROMBOPLASTIC FACTOR].
    KUZNIK BI; NAUMOV AD
    Vopr Med Khim; 1964; 10():140-4. PubMed ID: 14231597
    [No Abstract]   [Full Text] [Related]  

  • 31. A genetic nomenclature for human blood coagulation.
    Graham JB; Barrett DA; Blombäck B; Cann HM; Hardisty RM; Larrieu MJ; Renwick JH
    Thromb Diath Haemorrh; 1973 Sep; 30(1):2-11. PubMed ID: 4788752
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemical, clinical and immunological studies on the products of human plasma fractionation; the coagulation defect in hemophilia; an in vitro and in vivo comparison of normal and hemophilic whole blood, plasma and derived plasma protein fractions.
    LEWIS JH; DAVIDSON CS
    J Clin Invest; 1946 Nov; 25(6):870-5. PubMed ID: 20282729
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes of antigenecity of blood clotting factors during the process of blood coagulation (author's transl)].
    Fujimaki M; Iematsu S; Kato M; Kogiso H; Matsubara Y
    Rinsho Byori; 1978; 26(4):298-304. PubMed ID: 671776
    [No Abstract]   [Full Text] [Related]  

  • 34. [HEMOPHILIA AND ALLIED DISEASES].
    YOSHIDA K
    Nihon Ishikai Zasshi; 1964 Mar; 51():731-50. PubMed ID: 14141873
    [No Abstract]   [Full Text] [Related]  

  • 35. RESULTS with antihemophilic plasma.
    N Y State J Med; 1953 Mar; 53(5):559. PubMed ID: 13037057
    [No Abstract]   [Full Text] [Related]  

  • 36. The conversion of plasma-accelerator into serum-accelerator in haemophilia.
    VAN CREVELD S; PAULSSEN MM
    Acta Physiol Pharmacol Neerl; 1951; 2(1):129-33. PubMed ID: 14877576
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibitors of the first phase of coagulation in cases other than hemophilia].
    FAVRE-GILLY J; THOUVEREZ JP
    Sang; 1959; 30():351-76. PubMed ID: 13821774
    [No Abstract]   [Full Text] [Related]  

  • 38. [HEMORRHAGIC DIATHESIS CAUSED BY A DEFICIENCY OF PLASMA-THROMBOPLASTIN-ANTECEDENT (PTA)].
    DE VRIES SI; BRAAT-VANSTRAATEN MA
    Ned Tijdschr Geneeskd; 1964 Jan; 108():118-27. PubMed ID: 14141156
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of dilution on coagulation of plasma in vitro (normal coagulation, retarded coagulation and hemophilic coagulation].
    GUILLOT M; FIEHRER A; GUIET R
    Sang; 1950; 21(8):732-40. PubMed ID: 14787334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.